- জেনেরিক নাম
- Rifampicin
- শক্তি
- 150 mg
- ডোজ ফর্ম
- Capsule
- প্রস্তুতকারক
- KDH Laboratories Ltd.
Refam Capsule
Refam 150 mg Capsule সম্পর্কে
Refam 150 mg Capsule একটি ক্যাপসুল ঔষধ, যার জেনেরিক নাম Rifampicin এবং শক্তি ১৫০ mg। Rifampicin-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। এই ব্র্যান্ডের প্রস্তুতকারক KDH Laboratories Ltd। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।
Rifampicin-এর ১৮টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম Firifam 150 mg Tablet-এর, প্রতি ইউনিট ৳ ১।
Refam 150 mg Capsule কী?
Refam 150 mg Capsule is an anti-tubercular antibiotic. Its active ingredient, rifampicin, binds to a bacterial enzyme needed for RNA synthesis, thereby blocking RNA transcription and stopping bacterial growth. Doctors prescribe it as part of combination therapy for tuberculosis and for meningococcal carrier states. Because resistant bacteria can quickly dominate, laboratory testing before treatment helps confirm susceptibility. This medicine may interact with many other drugs and can affect liver function, so tell your doctor about all medicines you take and any liver problems. Always use it under medical supervision.
Refam-এর ব্যবহার
Refam 150 mg Capsule is used in the treatment of tuberculosis, usually alongside other anti-tubercular medicines. It is also used for the meningococcal carrier state. Rifampicin belongs to the rifamycin group of antibiotics. It is not a treatment for viral infections. Your doctor will decide whether this medicine is appropriate for your condition based on tests and clinical assessment.
Refam কীভাবে ব্যবহার করবেন
Take Refam 150 mg Capsule exactly as your doctor prescribes. The doctor decides the dose, frequency, and duration of treatment. Swallow the capsule with a full glass of water. It is usually recommended to take oral rifampicin once daily, either one hour before or two hours after a meal. Do not stop or change the schedule without medical advice. If you miss a dose, ask your doctor or pharmacist what to do.
Refam-এর পার্শ্বপ্রতিক্রিয়া
Common side effects include facial flushing and itching, with or without a rash, and flu-like symptoms such as fever, chills, headache, dizziness, bone pain, and shortness of breath. Gastrointestinal effects like nausea, vomiting, loss of appetite, and diarrhoea may occur. Rifampicin commonly causes orange-red discolouration of urine, faeces, sweat, saliva, sputum, and tears. Other effects include changes in kidney function, menstrual disturbances, and muscle weakness. Rarely, eye irritation may occur. Contact your doctor if side effects are troublesome.
সতর্কতা ও নিরাপত্তা
Do not take Refam 150 mg Capsule if you have a history of allergy to rifampicin or other rifamycins. It must not be used with ritonavir-boosted saquinavir or with atazanavir, darunavir, fosamprenavir, saquinavir, or tiprenavir due to serious risks. Rifampicin can cause liver dysfunction; patients with liver impairment should use it only if necessary and under strict medical supervision, with liver function monitoring. It may interact with many medicines, including antacids, ketoconazole, phenytoin, and halothane. In late pregnancy, it can cause bleeding in mother and infant. Breastfeeding decisions should be made with the doctor.
সাধারণ প্রশ্ন
What is Refam 150 mg Capsule used for and what kind of medicine is it?
Refam 150 mg Capsule is an antibiotic containing rifampicin, used in the treatment of tuberculosis and the meningococcal carrier state. It belongs to the anti-tubercular antibiotics class. It is usually given as part of a combination regimen. Your doctor will determine if it is suitable for your condition.
How should Refam 150 mg Capsule be taken?
Take it exactly as your doctor prescribes. Swallow the capsule with a full glass of water. Oral rifampicin is usually taken once daily, either one hour before or two hours after a meal. The doctor decides the dose and how long you need to take it. Do not stop treatment without medical advice.
Who should avoid Refam 150 mg Capsule or ask the doctor first?
People allergic to rifampicin or other rifamycins should not take it. It is also contraindicated with certain antiviral medicines such as ritonavir-boosted saquinavir, atazanavir, darunavir, fosamprenavir, saquinavir, and tipranavir. Those with liver problems, pregnant or breastfeeding women, and anyone taking other medicines should consult the doctor first.
What should I know about side effects and interactions of Refam 150 mg Capsule?
It may cause orange-red discolouration of body fluids, flu-like symptoms, and stomach upset. Serious liver problems can occur, especially with other liver-toxic drugs. It interacts with many medicines, including antacids, ketoconazole, phenytoin, and halothane. Tell your doctor about all medicines you take and report any unusual symptoms promptly.
নির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
In the treatment of both tuberculosis and the meningococcal carrier state, the small number of resistant cells present within large populations of susceptible cells can rapidly become the predominant type. Bacteriologic cultures should be obtained before the start of therapy to confirm the ... Read moreIn the treatment of both tuberculosis and the meningococcal carrier state, the small number of resistant cells present within large populations of susceptible cells can rapidly become the predominant type. Bacteriologic cultures should be obtained before the start of therapy to confirm the susceptibility of the organism to rifampinand they should be repeated throughout therapy to monitor the response to treatment. Since resistance can emerge rapidly, susceptibility tests should be performed in the event of persistent positive cultures during the course of treatment. If test results show resistance to rifampin and the patient is not responding to therapy, the drug regimen should be modified.ফার্মাকোলজি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rifampicin suppresses initiation of chain formation for RNA synthesis in susceptible bacteria by binding to the β subunit of DNA-dependent RNA polymerase, thus blocking RNA transcription.মাত্রা ও সেবনবিধি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rifampin can be administered by the oral route or by IV infusion. IV doses are the same as those for oral.Tuberculosis:
- Adults: 10 mg/kg, in a single daily administration, not to exceed 600 mg/day, oral or IV
- Pediatric Patients: 10–20 mg/kg, not to exceed 600 mg/day, oral or IV
Rifampin is indicated in the treatment of all forms of tuberculosis. A three-drug regimen consisting of rifampin, isoniazid, and pyrazinamide is recommended in the initial phase of shortcourse therapy which is usually continued for 2 months. The Advisory Council for the Elimination of Tuberculosis, the American Thoracic Society, and the Centers for Disease Control and Prevention recommend that either streptomycin or ethambutol be added as a fourth drug in a regimen containing isoniazid (INH), rifampin and pyrazinamide for initial treatment of tuberculosis unless the likelihood of INH resistance is very low. The need for a fourth drug should be reassessed when the results of susceptibility testing are known. If community rates of INH resistance are currently less than 4%, an initial treatment regimen with less than four drugs may be considered.
Following the initial phase, treatment should be continued with rifampin and isoniazid for at least 4 months. Treatment should be continued for longer if the patient is still sputum or culture positive, if resistant organisms are present, or if the patient is HIV positive.
ঔষধের মিথষ্ক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
May accelerate the metabolism and reduce the effect of drugs that are metabolised by CYP450 enzymes (e.g. quinidine, phenytoin, theophylline). Decreased concentrations of atovaquone and increased concentrations of rifampicin when taken concomitantly. Concurrent use of ketoconazole and rifampicin may result in decreased serum concentrations of both drugs. May decrease serum concentrations of enalaprilat. Reduced absorption by antacids. Increased risk of hepatotoxicity with halothane or isoniazid.প্রতিনির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rifampicin is contraindicated in patients with a history of hypersensitivity to rifampin or any of the components, or to any of the rifamycins. Rifampin is contraindicated in patients who are also receiving ritonavir-boosted saquinavir due to an increased risk of severe hepatocellular toxicity.Rifampin is contraindicated in patients who are also receiving atazanavir, darunavir, fosamprenavir, saquinavir, or tipranavir due to the potential of rifampin to substantially decrease plasma concentrations of these antiviral drugs, which may result in loss of antiviral efficacy and/or development of viral resistance.
পার্শ্ব প্রতিক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Facial flushing and itching, with or without a rash, flu-like syndrome characterised by episodes of fever, chills, headache, dizziness, bone pain, shortness of breath, and malaise; GI adverse effects (e.g. nausea, vomiting, anorexia, diarrhoea, epigastric distress), pseudomembranous colitis, eosinophilia, leucopenia, haemolytic anaemia; alterations in kidney function and renal failure, menstrual disturbances, oedema, myopathy, muscular weakness; orange-red discolouration of the urine, faeces, sweat, saliva, sputum, tears, and other body fluids; thrombophlebitis, local irritation and inflammation after prolonged IV infusion. Rarely, eye irritation and visual disturbances, anaphylaxis or shock.গর্ভাবস্থায় ও স্তন্যদানকালে
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregnancy: When administered during the last few weeks of pregnancy, rifampin can cause post natal hemorrhages in the mother and infant for which treatment with vitamin K may be indicated.Nursing Mothers: Because of the potential for tumorigenicity shown for rifampin in animal studies, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
সতর্কতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rifampicin has been shown to produce liver dysfunction. Fatalities associated with jaundice have occurred in patients with liver disease and in patients taking rifampin with other hepatotoxic agents. Patients with impaired liver function should be given rifampin only in cases of necessity and then with caution and under strict medical supervision. In these patients, careful monitoring of liver function, especially SGPT/ALT and SGOT/AST should be carried out prior to therapy and then every 2 to 4 weeks during therapy. If signs of hepatocellular damage occur, rifampin should be withdrawn.In some cases, hyperbilirubinemia resulting from competition between rifampin and bilirubin for excretory pathways of the liver at the cell level can occur in the early days of treatment. An isolated report showing a moderate rise in bilirubin and/or transaminase level is not in itself an indication for interrupting treatment; rather, the decision should be made after repeating the tests, noting trends in the levels, and considering them in conjunction with the patient's clinical condition.
Rifampin has enzyme-inducing properties, including induction of delta amino levulinic acid synthetase. Isolated reports have associated porphyria exacerbation with rifampin administration.
মাত্রাধিক্যতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Nausea, vomiting, abdominal pain, pruritus, headache, and increasing lethargy will probably occur within a short time after ingestion; unconsciousness may occur when there is severe hepatic disease. Transient increases in liver enzymes and/or bilirubin may occur. Brownish-red or orange discoloration of the skin, urine, sweat, saliva, tears, and feces will occur, and its intensity is proportional to the amount ingested.Liver enlargement, possibly with tenderness, can develop within a few hours after severe overdosage; bilirubin levels may increase and jaundice may develop rapidly. Hepatic involvement may be more marked in patients with prior impairment of hepatic function. Other physical findings remain essentially normal. A direct effect upon the hematopoietic system, electrolyte levels, or acid-base balance is unlikely.
Facial or periorbital edema has also been reported in pediatric patients. Hypotension, sinus tachycardia, ventricular arrhythmias, seizures and cardiac arrest were reported in some fatal cases.
সংরক্ষণ
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Store between 15-30° C. Avoid excessive heat and protect from light.বিকল্প ব্র্যান্ড: Rifampicin
একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।